Back to Agenda
Session 6: Development Specifics for Combination Product
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- General Development Strategy
- Clinical and Preclinical
- Human Factors Studies
Have an account?